Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001235802-21-000100)

Filing Details

Accession Number:: 0001235802-21-000100
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-08-17 16:05:23
Reporting Period:: 2021-08-16

Accepted Time:: 2021-08-17 16:05:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1401040	Diamedica Therapeutics Inc.	DMAC	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1760016	D. Richard Pilnik	Two Carlson Parkway, Suite 260 Minneapolis MN 55447		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Voting Common Shares, No Par Value Per Share	Acquisiton	2021-08-16	2,500	$3.21	83,065	No	4	P	Direct
Voting Common Shares, No Par Value Per Share	Acquisiton	2021-08-16	12,500	$3.28	95,565	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 19,887 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan.